Abstract
CD28-deficient T cells arrest at the G1-S transition of the cell cycle. Here we show that this is controlled by the kinase aurora B, which exists in a complex with survivin and mammalian target of rapamycin (mTOR). Expression of aurora B in Cd28-/- T cells augmented phosphorylation of mTOR substrates, expression of cyclin A, hyperphosphorylation of retinoblastoma protein and activation of cyclin-dependent kinases 1 and 2 and promoted cell cycle progression. Interleukin 2 enhanced aurora B activity, and inactive aurora B prevented interleukin 2-induced proliferation. Moreover, expression of aurora B restored Cd28-/- T cell proliferation and promoted inflammation in vivo. These data identify aurora B, along with survivin and mTOR, as a regulator of the G1-S checkpoint in T cells.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 64-73 |
| Number of pages | 10 |
| Journal | Nature Immunology |
| Volume | 8 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2007 |
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Immunology
Fingerprint
Dive into the research topics of 'The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver